In the broker and risk consultancy’s report, “D&O Looking Ahead Guide: D&O Considerations for 2023", Woodruff Sawyer said the shift impacted IPO, life science and technology companies the most – the companies that were hit hardest by the upward...
D&O pricing softens in first half of 2022: Woodruff Sawyer
